House of representatives investigates FDA action to regulate cannabidiol (CBD) products as dietary supplements
USA
Apr 17, 2023
House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) is investigating the Food and Drug Administration’s (FDA) failure to regulate cannabidiols (CBD) products as dietary supplements. In a letter to the Commissioner of Food and Drugs at the FDA, Dr. Robert M. Califf, Chairman Comer raises concern that the agency’s failure to regulate CBD products could allow dangerous products to come to market and is requesting documents and information to enable oversight of the FDA’s failure to provide Americans with regulatory guidance.
For further information (in English), click on the Link
Hemp seeds authorized for use in foodstuffs
Argentina
Dec 07, 2023
New Online Platform for the Management of Cannabis Derivatives Manufacturing Licenses
Colombia
Nov 09, 2023
The FSA updates recommendations on foods with CBD
UK
Oct 12, 2023
New regulation on medical cannabis and industrial hemp published
Argentina
Aug 08, 2023
Hemp-derived CBD products to be authorized soon
USA
Jul 20, 2023
Hemp seeds and hemp derived products to be regulated soon
Argentina
Jul 18, 2023
MFDS bans 9 substances in food
South Korea
Jun 14, 2023
Prime Minister disagrees with CBD prohibition bill
Czech Republic
May 17, 2023
Blanket ban on CBD products
Czech Republic
May 02, 2023
Bills re-introduced to regulate Hemp-Derived CBD
USA
Mar 22, 2023
EU - Does Cannabidiol (CBD) in Food Supplements Pose a Serious Health Risk? Consequences of the European Food Safety Authority (EFSA) Clock Stop Regarding Novel Food Authorisation
European Union
Mar 20, 2023
Existing regulatory frameworks for foods and supplements are not appropriate for Cannabidiol
USA
Jan 30, 2023
Maximum levels of Δ9-THC in hemp seeds and derived products
European Union
Jan 30, 2023
Marketing authorization for hemp seeds and hemp seed products
India
Nov 21, 2022
New requirements to control the use of cannabis in food
Thailand
Oct 21, 2022
